The CD56+ NK cells from tumors were identified by CD56+ staining in the lymphocyte population (identified through their forward/side scatter properties), which had previously been identified as being smaller than the cancer cells and monocytes (red and green circles, respectively; Additional file 2: Figure S2B). The gene discussed is NCAM1; the disease is cancer.